The earnings call highlighted significant challenges, including a decline in global and U.S. sales, an impairment charge, and a drop in EPS. While there were positive aspects such as growth in European sales and Wellspect Healthcare, these were overshadowed by the broader financial difficulties and strategic challenges. The sentiment is more negative due to the pressing issues and the focus on a turnaround strategy.
Company Guidance
During the Q3 2025 earnings call, DENTSPLY SIRONA provided guidance for the remainder of the fiscal year, revising their 2025 outlook based on recent results and external impacts. The company expects net sales to be in the range of $3.6 billion to $3.7 billion, with constant currency sales projected to decline between 4% and 5% year-over-year. Adjusted EPS is anticipated to be approximately $1.60. In Q3 2025, global sales decreased by 5% to $904 million, with adjusted EBITDA improving to 18.4%. The earnings per share fell by $0.13 to $0.37, impacted by a higher non-GAAP tax rate of 32%. The company also recorded a significant noncash after-tax charge of $263 million due to goodwill and intangible asset impairments. As part of their strategic focus, DENTSPLY SIRONA is implementing a Return-to-Growth action plan to deliver sustained profitable growth over the next 24 months, focusing on customer-centricity, reigniting U.S. business, empowering employees, and operational evolution.
European Sales Growth
European sales were $382 million, increasing 9.9% as reported or 2.6% on a constant currency basis, driven by growth in Connected Technology Solutions and Labs. The U.K., France, Italy, and Spain had strong constant currency growth.
Wellspect Healthcare Sales Increase
Sales in constant currency for Wellspect Healthcare increased 9.3% with growth across all three regions. This segment is expected to play a key role in achieving financial goals.
Return to Shareholders
DENTSPLY SIRONA returned $32 million to shareholders through dividends in the third quarter, with $96 million returned year-to-date.
DENTSPLY SIRONA (XRAY) Earnings, Revenues Date & History
The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
XRAY Earnings-Related Price Changes
Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 06, 2025
$12.62
$11.02
-12.68%
Aug 07, 2025
$13.50
$13.06
-3.26%
May 08, 2025
$13.37
$15.55
+16.31%
Feb 27, 2025
$18.19
$16.59
-8.80%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does DENTSPLY SIRONA Inc (XRAY) report earnings?
DENTSPLY SIRONA Inc (XRAY) is schdueled to report earning on Feb 26, 2026, Before Open (Confirmed).
What is DENTSPLY SIRONA Inc (XRAY) earnings time?
DENTSPLY SIRONA Inc (XRAY) earnings time is at Feb 26, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.